| David Henderson, MD | |
|
531 Polk 77, Mena, AR 71953-7848 | |
| (479) 437-3602 | |
| (479) 437-3604 |
| Full Name | David Henderson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 531 Polk 77, Mena, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306995527 | NPI | - | NPPES |
| E3000 | Other | AR | STATE LICENSE # |
| 5L920 | Other | AR | BLUE CROSS BLUE SHIELD |
| 145341001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | E3000 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aaa Of Western Ark Inc Mena | Mena, AR | Hospice |
| Mena Regional Health System | Mena, AR | Hospital |
| National Park Medical Center | Hot springs, AR | Hospital |
| The Green House Cottages Of Homewood | Mena, AR | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mena Family Health Center | 3971629155 | 5 |
| Access Medical Clinic Arkansas Llc | 5890077093 | 136 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.
With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic Medicine.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
› Verified 2 days ago
| Entity Name | Mena Hospital Commission |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285739581 PECOS PAC ID: 8527057678 Enrollment ID: O20040512000557 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.
With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic Medicine.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
› Verified 2 days ago
| Entity Name | Mena Family Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447571047 PECOS PAC ID: 3971629155 Enrollment ID: O20100924000616 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.
With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic Medicine.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
› Verified 2 days ago
| Entity Name | Access Medical Clinic Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578007647 PECOS PAC ID: 5890077093 Enrollment ID: O20170124001288 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.
With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic Medicine.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Henderson, MD 531 Polk 77, Mena, AR 71953-7848 Ph: (479) 437-3602 | David Henderson, MD 531 Polk 77, Mena, AR 71953-7848 Ph: (479) 437-3602 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.
With elections coming up in Haiti, major earthquakes, a cholera epidemic and fears of political violence rear their ugly heads in the Western Hemisphere's poorest nation. Electoral officials still say the presidential and legislative polls will go ahead as scheduled on November 28, despite the cholera outbreak. The epidemic has killed more than 290 people and sickened more than 4,000 since last week, triggering a major multinational treatment and prevention operation.
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic Medicine.
Approximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, study findings suggest.
› Verified 2 days ago
Dr. Richard E. Eccles, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1103 College Dr, Mena, AR 71953 Phone: 479-394-1414 Fax: 479-243-2468 | |
Dr. Mary Amanda Fitzgerald, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 136 Health Park Drive, Mena, AR 71953 Phone: 479-437-3449 Fax: 479-437-3449 | |
Kristen Wortman Sager, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 501-624-7700 Fax: 501-623-5788 | |
Mr. Paul Benjamin Buschman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 North Morrow Street, Mena, AR 71953 Phone: 479-394-6100 Fax: 479-394-4577 |